BackVeraxa Biotech Holding AG Overview

Veraxa Biotech Holding AG Common Stock

Veraxa Biotech Holding AG's common stock is $540M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$544.52M
↑ 3.90% YoYΔ $20.43M vs prior year quarter

Peer trimmed avg / median

Loading

Veraxa Biotech Holding AG Common Stock History

Loading

Veraxa Biotech Holding AG vs. peers: Common Stock Comparison

Loading

Veraxa Biotech Holding AG Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Veraxa Biotech Holding AG (VRXA) FAQ

As of the most recent data (March 2026), VRXA shows a common stock of $540M. That compares with $520M in the prior-year period — up 3.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VRXA's common stock is now $540M (was $520M) — a 3.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Veraxa Biotech Holding AG is outperforming or lagging.

Tracking VRXA's common stock over time shows whether Veraxa Biotech Holding AG is scaling, shrinking, or reshaping that part of the business. The current reading is $540M That compares with $520M in the prior-year period — up 3.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Veraxa Biotech Holding AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $540M) with ownership activity and broader fundamentals.